je.st
news
OXiGENE Now Covered by MLV & Co
2014-11-08 19:31:27| Biotech - Topix.net
The firm set a "buy" rating and a $6.50 price target on the stock. MLV & Co 's price target suggests a potential upside of 200.93% from the stock's previous close.
Tags: co
covered
oxigene
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||